University of Nevada, Reno engineers use molecular and pathological signatures in study

in Local News

RENO, Nev. (News 4 & Fox 11) — University of Nevada, Reno Biomedical Engineer, Bahram Parvin, is researching an initiative that can be used to tailor treatment options for brain tumors based on the patient’s unique molecular and pathology signatures.

The overall goal is to identify biomarkers of the adult brain tumors based on pathogenomic signatures that are predictive of a particular therapy.

Continue Reading on